The (R)evolution of Melanoma Care.

Surg Oncol Clin N Am

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute of Emory University School of Medicine, 1365 Clifton Road NE, Atlanta, GA 30322, USA. Electronic address:

Published: July 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2020.03.002DOI Listing

Publication Analysis

Top Keywords

revolution melanoma
4
melanoma care
4
revolution
1
care
1

Similar Publications

Background: Data on the safety profiles and clinical outcomes of patients with solid tumors and cardiac metastasis treated with immune checkpoint inhibitors (ICIs) are limited.

Methods: This is an international multicenter retrospective study of patients with cancer and cardiac metastasis at baseline. Patients who had received ≥1 dose of ICI were included.

View Article and Find Full Text PDF

This paper proposes a Tangent Rat Swarm Optimization (TRSO)-DenseNet for the detection of skin cancer to reduce the severity rate of cancer. Initially, the input image is pre-processed by employing a linear smoothing filter. The pre-processed image is transferred to skin lesion segmentation, where Mask-RCNN is utilized for segmenting the skin lesion.

View Article and Find Full Text PDF

Skin melanoma is very rarely found in the genital region. Additionally, out of all penile skin malignancies, melanoma is one of the rarest, with no cases reported before in the Balkan region. A 68-year-old male presented with atypical and irregular pigmented skin lesions on his left flank and penile shaft.

View Article and Find Full Text PDF

Objective: Cancer patients aged ≥80 years present unique characteristics affecting response to immune checkpoint inhibitors (ICIs), with unidentified molecular differences. This study aimed to explore potential biomarkers of response to ICI in patients ≥80 years.

Methods And Analysis: We analysed tumour samples (n=24 123) from patients ≥80 (versus<80) with non-small cell lung cancer (NSCLC), melanoma (MEL), and renal cell cancer (RCC).

View Article and Find Full Text PDF

Background: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are the most prevalent subtypes of melanoma, primarily affecting sun-exposed areas of the face in individuals aged 65 to 80 years. LM accounts for approximately 80 % of in situ melanomas and carries a risk of progression to LMM, which constitutes 4 % to 15 % of global cutaneous melanoma cases. This report discusses the clinical challenges and management strategies for recurrent LM, with an emphasis on accurate diagnosis and surgical intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!